DUPHAT 2023 concludes with commercial deals

The 28th Dubai International Pharmacy Technology Conference and Exhibition DUPHAT 2023 concluded yesterday in Dubai, generating exceptional interest from pharmaceutical industry stakeholders. During the three-day global event, commercial deals worth over AED 6.12 billion were concluded, an increase of 20% on the previous year.

The DUPHAT exhibition, organised by INDEX Conferences and Exhibitions for the past 28 years, is one of the largest scientific and medical events in the Middle East and Africa region. This year, a total of 1,147 companies from 82 countries exhibited their pharmaceutical and medical products at the fair. DUPHAT 2023, which attracted more than 26,000 visitors from around the world, also showcased a wide range of pharmaceutical innovations.

The high quality platform provided by DUPHAT for pharmaceutical industry stakeholders to explore partnerships and commercial opportunities has resulted in many local and international companies confirming their participation in upcoming events. DUPHAT allows industry participants to find new customers, suppliers and pharmaceutical manufacturers. The organisers expect participation in the next edition of DUPHAT to increase by 30%.

The conference has become a forum for the exchange of new knowledge and experience in various fields of medicine and pharmaceuticals. Leading physicians and pharmaceutical experts from the US, Europe, Gulf States and other regions discussed the role of pharmacists in curbing the spread of COVID-19. Other vital issues discussed at this year’s DUPHAT included the use of medicines during pregnancy, clinical pharmacy practice, public health and therapeutic drug monitoring.

The next edition of DUPHAT, which will be organised by INDEX Conferences and Exhibitions, part of the INDEX holding company, will take place in January 2024. The event is supported by the Dubai Health Authority, American Society of Public Health Pharmacists, International Society of Pharmacoepidemiology, European Federation of Pharmaceutical Sciences, European Society of Clinical Pharmacy and European Society of Oncology Pharmacy.

Follow our Telegram Chanel